| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Obstetrics and Gynecology, John Hunter Hospital (T.Z.); and Discipline of Reproductive Medicine (R.F.J., T.Z.) and Mothers and Babies Research Center (R.F.J., C.M.M., V.C., T.Z.), University of Newcastle, Newcastle, New South Wales 2310, Australia
Address all correspondence and requests for reprints to: Dr. Tamas Zakar, Division of Obstetrics and Gynecology, Mothers and Babies Research Center, John Hunter Hospital, Locked Bag 1, Hunter Region Mail Center, Newcastle, New South Wales 2310, Australia. E-mail: tzakar{at}mail.newcastle.edu.au.
The prostaglandin (PG)-inactivating enzyme 15-hydroxyprostaglandin dehydrogenase (PGDH) is highly expressed in the chorion leave. To assess the involvement of PGDH in the regulation of intrauterine PG levels, we have determined the mechanisms that control chorionic PGDH expression in women at term and preterm labor. PGDH gene activity decreased at term and during normal labor. PGDH mRNA abundance also decreased at term due to changing splice variant distribution. Gene activity predicted PGDH mRNA abundance preterm and after normal labor, but not at term before labor. PGDH mRNA decayed rapidly in cultured tissues and was stabilized by transcriptional arrest. PGDH protein levels varied without being significantly different between the patient groups. PGDH mRNA levels predicted PGDH protein levels at term, but not preterm and after labor. PGDH gene activity, mRNA variant, and immunoreactive protein levels were not different between the preterm labor and preterm not in labor groups. Thus, PGDH mRNA is transiently down-regulated before term labor by a posttranscriptional mechanism(s). Protein turnover controls PGDH protein abundance at preterm and after normal labor. At term, PGDH protein levels become dependent on the rapidly turning over PGDH mRNA. This may allow rapid changes in PGDH protein abundance and uterotonic PG concentrations promoting labor.
This article has been cited by other articles:
![]() |
L. Gao, C. Lu, C. Xu, Y. Tao, B. Cong, and X. Ni Differential Regulation of Prostaglandin Production Mediated by Corticotropin-Releasing Hormone Receptor Type 1 and Type 2 in Cultured Human Placental Trophoblasts Endocrinology, June 1, 2008; 149(6): 2866 - 2876. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.M. Mitchell, R.F. Johnson, W.B. Giles, and T. Zakar Prostaglandin H synthase-2 gene regulation in the amnion at labour: histone acetylation and nuclear factor kappa B binding to the promoter in vivo Mol. Hum. Reprod., January 1, 2008; 14(1): 53 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gao, P. He, J. Sha, C. Liu, L. Dai, N. Hui, and X. Ni Corticotropin-Releasing Hormone Receptor Type 1 and Type 2 Mediate Differential Effects on 15-Hydroxy Prostaglandin Dehydrogenase Expression in Cultured Human Chorion Trophoblasts Endocrinology, August 1, 2007; 148(8): 3645 - 3654. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Smith Parturition N. Engl. J. Med., January 18, 2007; 356(3): 271 - 283. [Full Text] [PDF] |
||||
![]() |
R. F Johnson, C. M Mitchell, W. B Giles, A. Bisits, and T. Zakar Mechanisms regulating prostaglandin H2 synthase-2 mRNA level in the amnion and chorion during pregnancy. J. Endocrinol., March 1, 2006; 188(3): 603 - 610. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |